MetaCap

HealthEquity Inc. (HQY)

NASDAQ: HQYConsumer DiscretionaryBusiness ServicesUSD

93.05+1.15 (+1.25%)

At close: Oct 8, 4:00 PM ET · Delayed 15 min

HQY stock chart

Technical analysis

Key statistics

All statistics
52-week range
72.76 – 107.62
Day range
91.47 – 93.54
Volume / Avg
772.77K / 841.36K
Beta
—

52-week range

$72.76$107.62

HQY stock today

On Oct 8, HQY ended the session at $93.05, adding $1.15 (1.25%), versus the S&P 500's 0.47% decline. At this level, HQY sits in the middle of its 52-week range of $72.76 to $107.62: 13.5% below the high, set on Aug 10, 2026 and 27.9% above the low. HQY is up 1.6% year to date, underperforming the S&P 500 (+13.5%). Over the past 12 months, the stock has gained 1.0%.

At 33.6x trailing earnings, HealthEquity trades above the peer-group median of 22.0x. Its forward P/E of 16.9x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year.

Summary generated from market data by MetaCap's automated system. Methodology

About HealthEquity

Company profile

HealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States. It offers health savings accounts (HAS); investment platform; online-only automated investment advisory services through Advisor, a Web-based tool.

Industry
Business Services
CEO
Mr. Scott R. Cutler J.D.
Headquarters
Draper, UT
Employees
2,814
IPO year
2014

Financial highlights

Full financials

In fiscal 2026, HealthEquity generated $1.31 billion in revenue, up 9.5% from fiscal 2025, its 13th consecutive year of revenue growth. Net income was $215.2 million (+122.5% year over year), for a net margin of 16.4% versus a median of 1.2% in the prior 5 years. Gross margin was 69.5% (up from 64.8%) and operating margin 24.6%.

HealthEquity annual revenue, net income and EPS
Fiscal yearFY 2026FY 2025FY 2024FY 2023FY 2022
Revenue$1.31B$1.20B$999.59M$861.75M$756.56M
Growth+9.47%+20.03%+16.00%+13.90%+3.13%
Net income$215.20M$96.70M$55.71M$-26.14M$-44.29M
EPS (diluted)$2.46$1.09$0.64$-0.31$-0.53

Analyst forecast

Forecast

Consensus (15 analysts)

strong_buy

Avg. price target

$119.33+28.24%

  • Strong buy 5
  • Buy 10
  • Hold 0
  • Sell 0
  • Strong sell 0

Target range

Low $105.00High $142.00

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

Earnings

Earnings history
Last reported (Q2 2027)
Aug 27, 2026
EPS actual vs est.
$0.78 vs —

HQY news

All HQY news

HealthEquity peers

Consumer Discretionary sector
HQY peer companies
CompanyPrice% ChgMarket capCompare
ETSYEtsy Inc.75.14+5.11%$6.90Bvs HQY
ZGZillow Group Inc. Class A29.90+6.90%$6.72Bvs HQY
ZZillow Group Inc. Class C29.17+6.93%$6.56Bvs HQY
LYFTLyft Inc. Class A16.13+3.40%$6.11Bvs HQY
XMTRXometry Inc. Class A106.48-1.22%$6.10Bvs HQY
WEXWEX Inc.174.41+2.62%$5.94Bvs HQY
MBGLMobility Global Inc.18.08+4.09%$5.79Bvs HQY
RELYRemitly Global Inc.23.52+2.57%$4.98Bvs HQY

Indexes, lists and sector

HealthEquity stock FAQ

What is HealthEquity's stock price today?

HQY last traded at $93.05 as of Oct 8, 4:00 PM EDT, up 1.25% on the day. Prices are delayed at least 15 minutes.

What is HQY's P/E ratio?

HQY trades at a trailing P/E ratio of 33.59 and a forward P/E of 16.92, compared with a median of 22.0 for its closest peers.

Who is HealthEquity's CEO?

Mr. Scott R. Cutler J.D. is the chief executive officer of HealthEquity Inc., which has about 2,814 employees.

What is the HQY 52-week high?

The 52-week high for HQY is $107.62 and the 52-week low is $72.76. The stock is currently 13.5% below its high.

Compare HQY